Cargando…

Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia

We report successful treatment of adult respiratory distress syndrome (ARDS) with artificial surfactant (40mg/kg, Colfosceril Palmitate, ‘Exosurf’, Wellcome) in an infant with severePneumocystis carinii pneumonitis.

Detalles Bibliográficos
Autores principales: Slater, A. J., Nichani, S. H., Macrae, D., Wilkinson, K. A., Novelli, V., Tasker, R. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094930/
https://www.ncbi.nlm.nih.gov/pubmed/7790617
http://dx.doi.org/10.1007/BF01701485
_version_ 1783510561275772928
author Slater, A. J.
Nichani, S. H.
Macrae, D.
Wilkinson, K. A.
Novelli, V.
Tasker, R. C.
author_facet Slater, A. J.
Nichani, S. H.
Macrae, D.
Wilkinson, K. A.
Novelli, V.
Tasker, R. C.
author_sort Slater, A. J.
collection PubMed
description We report successful treatment of adult respiratory distress syndrome (ARDS) with artificial surfactant (40mg/kg, Colfosceril Palmitate, ‘Exosurf’, Wellcome) in an infant with severePneumocystis carinii pneumonitis.
format Online
Article
Text
id pubmed-7094930
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70949302020-03-26 Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia Slater, A. J. Nichani, S. H. Macrae, D. Wilkinson, K. A. Novelli, V. Tasker, R. C. Intensive Care Med Neonatal and Pediatric Intensive care We report successful treatment of adult respiratory distress syndrome (ARDS) with artificial surfactant (40mg/kg, Colfosceril Palmitate, ‘Exosurf’, Wellcome) in an infant with severePneumocystis carinii pneumonitis. Springer-Verlag 1995 /pmc/articles/PMC7094930/ /pubmed/7790617 http://dx.doi.org/10.1007/BF01701485 Text en © Springer-Verlag 1995 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Neonatal and Pediatric Intensive care
Slater, A. J.
Nichani, S. H.
Macrae, D.
Wilkinson, K. A.
Novelli, V.
Tasker, R. C.
Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title_full Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title_fullStr Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title_full_unstemmed Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title_short Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
title_sort surfactant adjunctive therapy forpneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
topic Neonatal and Pediatric Intensive care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094930/
https://www.ncbi.nlm.nih.gov/pubmed/7790617
http://dx.doi.org/10.1007/BF01701485
work_keys_str_mv AT slateraj surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia
AT nichanish surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia
AT macraed surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia
AT wilkinsonka surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia
AT novelliv surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia
AT taskerrc surfactantadjunctivetherapyforpneumocystiscariniipneumonitisinaninfantwithacutelymphoblasticleukaemia